Abstract:Background: Episodic ataxias are rare neurological disorders characterized by recurring episodes of imbalance and coordination difficulties. Obtaining definitive molecular diagnoses poses challenges, as clinical presentation is highly heterogeneous, and literature on the underlying genetics is limited. While the advent of high-throughput sequencing technologies has significantly contributed to Mendelian disorders genetics, interpretation of variants of uncertain significance and other limitations inherent to individual methods still leaves many patients undiagnosed. This study aimed to investigate the utility of multi-omics for the identification and validation of molecular candidates in a cohort of complex cases of ataxia with episodic presentation. Methods: Eight patients lacking molecular diagnosis despite extensive clinical examination were recruited following standard genetic testing. Whole genome and RNA sequencing were performed on samples isolated from peripheral blood mononuclear cells. Integration of expression and splicing data facilitated genomic variants prioritization. Subsequently, long-read sequencing played a crucial role in the validation of those candidate variants. Results: Whole genome sequencing uncovered pathogenic variants in four genes ( SPG7 , ATXN2 , ELOVL4 , PMPCB ). A missense and a nonsense variant, both previously reported as likely pathogenic, configured in trans in individual #1 ( SPG7 : c.2228T>C/p.I743T, c.1861C>T/p.Q621*). An ATXN2 microsatellite expansion (CAG 32 ) in another late-onset case. In two separate individuals, intronic variants near splice sites ( ELOVL4 : c.541 + 5G>A; PMPCB : c.1154 + 5G>C) were predicted to induce loss-of-function splicing, but had never been reported as disease-causing. Long-read sequencing confirmed the compound heterozygous variants configuration, repeat expansion length, as well as splicing landscape for those pathogenic variants. A potential genetic modifier of the ATXN2 expansion was discovered in ZFYVE26 (c.3022C>T/p.R1008*). Conclusion: Despite failure to identify pathogenic variants through clinical genetic testing, the multi-omics approach enabled the molecular diagnosis in 50% of patients, also giving valuable insights for variant prioritization in remaining cases. The findings demonstrate the value of long-read sequencing for the validation of candidate variants in various scenarios. Our study demonstrates the effectiveness of leveraging complementary omics technologies to unravel the underlying genetics in patients with unresolved rare diseases such as ataxia. Molecular diagnoses not only hold significant promise in improving patient care management, but also alleviates the burden of diagnostic odysseys, more broadly enhancing quality of life.

Genetic Causes of early onset Ataxia: Experience from the National Sheffield Paediatric Ataxia Centre.

A Familial Late-Onset Hereditary Ataxia Mimicking Pontocerebellar Hypoplasia Caused by A Novel Tsen54 Mutation

Etiologies and Clinical Characteristics of Acute Ataxia in a Single National Children's Medical Center.

Clinical and Genetic Characterization of a Cohort of Brazilian Patients With Congenital Ataxia

Targeted long-read sequencing as a single assay improves diagnosis of spastic-ataxia disorders

Analysis of Clinical and Genetic Characterization of Three Ataxia–Telangiectasia Pedigrees With Novel ATM Gene Mutations

NGS in Hereditary Ataxia: When Rare Becomes Frequent

Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?

Autosomal dominant cerebellar ataxias: new genes and progress towards treatments

Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias

Early-onset phenotype in a patient with an intermediate allele and a large SCA1 expansion: a case report

Investigation of recessive ataxia loci in patients with young age of onset

Integration of multi-omics technologies for molecular diagnosis in ataxia patients

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

The dynamic mutation investigation and whole exome sequencing in a cohort of Chinese autosomal dominant cerebellar ataxia patients

Other autosomal recessive and childhood ataxias

Bridging the gap: a prospective trial comparing programmable targeted long-read sequencing and short-read genome sequencing for genetic diagnosis of cerebellar ataxia

Late onset hereditary episodic ataxia

The genetic basis of early-onset hereditary ataxia in Iran: results of a national registry of a heterogeneous population

Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B)

Genetic Profile And Clinical Characteristics Of Chinese Patients With Spinocerebellar Ataxia Type 2: A Multicenter Experience Over 10 Years